over 100,000 people have already been scheduled

The administration of the AstraZeneca vaccine starts in Romania on Monday.

Those who are included in the second stage of the campaign, but who are not more than 55 years old, will be vaccinated with AstraZeneca. That is, chronically ill and essential staff. The campaign organizers entered 220,000 seats in the programming platform for the next 20 days. More than 100,000 people have already been scheduled.

COVID-19 AstraZeneca vaccine. Where there are still places for vaccination

More than 8,000 places are still available in Timiş.

There are almost 7,500 left in Iasi, and more than 5,000 in Suceava. Most places in Moldova are vacant.

The fewest are in the counties of South and South-East, Ialomiţa, Călăraşi, Constanţa or Brăila. Bucharest is no better either, there are only 1,500 vacancies left.

Vaccination campaign. When will there be more places for seniors

Schedules for Pfizer and Moderna vaccines are due by April 15th. If we get more vaccine, more appointments will be made, but there doesn’t seem to be a chance until mid-March.

After that, things seem to be getting better. Pfizer is starting to deliver the vaccine from a new factory in Germany and the Johnson & Johnson vaccine will most likely be approved.

Also, the recommendation for use for AstraZeneca is not nailed down. Data is constantly being analyzed, and if its effectiveness is proven for seniors, it will probably be extended to the age group for which it can be used.

For the most important news of the day, broadcast in real time and presented equidistantly, LIKE our Facebook page!

Follows Mediafax on Instagram to see spectacular images and stories from around the world!

The content of the website www.mediafax.ro is intended exclusively for your personal information and use. It is prohibited republishing the content of this site in the absence of an agreement from MEDIAFAX. To obtain this agreement, please contact us at [email protected]

Source: Mediafax by www.mediafax.ro.

*The article has been translated based on the content of Mediafax by www.mediafax.ro. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!